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Empowering caregivers to recognize, support, and treat patients with opioid use disorder: an interdisciplinary 
assessment of knowledge, attitudes, and comfort level pre and post-education
Annette Sprankle, PharmD, PGY1 Resident; Mika Michaels, PharmD, BCPP
Providence Medford Medical Center
• Substance use disorders affect approximately 25% of 
hospitalized patients.
• Up to 67% of patients with a substance use disorder admitted 
in the hospital reported that they were interested in cutting 
back or quitting.
• 44% of patients report wanting to try a medication to treat 
their opioid use disorder (OUD).
• Buprenorphine and methadone are FDA-approved for the 
treatment of OUD and are often referred to as medication-
assisted treatment, or MAT.
• A patient with opioid dependency who is admitted to the 
hospital for a primary problem other than opioid dependency 
may be administered opioid agonist medications such as 
methadone and buprenorphine to prevent opioid withdrawal 
that would complicate the primary medical problem.
This study aims to assess caregivers’ knowledge, attitudes, and 
comfort level surrounding the treatment of patients with opioid 
use disorder in the hospital utilizing medication-assisted 
treatment (MAT) before and after education. It also aims to 
involve more professional disciplines in the treatment of patients 
with opioid use disorder, identify barriers, and address them in a 
systematic way to increase access to medication-assisted 
treatment in the hospital and connect them to outpatient care.
Future Directions
Methods
Benefits of MAT
Decreases:
• Risk of overdose upon discharge 
• Overdose-related deaths
• Rate of hospital readmission
• Hospital expenditures
• Patients leaving against medical 
advice
• Risk of HIV
• Risk of Hepatitis C infection
• Rates of cellulitis
• Rates of HIV risk behavior
• Rates of criminal behavior 
Primary Outcomes Secondary Outcomes
Change in knowledge, attitudes, and 
comfort level surrounding OUD and 
MAT after education
Change in number of patients started 
on buprenorphine or methadone in 
the hospital 
3 months of 
prescribing data 
collected
Pre-
education 
survey
Education 
Performed
Post-
education 
survey
3 months of 
prescribing data 
collected
Results Table 1: Survey Questions – All disciplines
Answers based on a 5-point Likert scale rated from strongly disagree (1) to strongly agree (5)
P-value Pre-Education 
Mean
Post-Education 
Mean
We should be offering patients with opioid use disorder medications to treat their withdrawal. 0.0222 3.12 4.58
MAT (Medication Assisted Treatment with buprenorphine or methadone) decreases admission rates for 
patients with opioid use disorder.
0.00049 3.27 4.11
Patients with opioid use disorder in severe pain should be offered opioids (i.e. hydrocodone, oxycodone) 
while in the hospital.
0.106 3.80 4.16
Many patients that have an opioid use disorder want to quit or reduce the amount of substance they are 
currently using.
0.00075 3.03 3.95
Patients who do not wish to seek addiction treatment outside of the hospital should not be offered 
methadone or buprenorphine while inpatient.
0.00706 2.93 2.21
I feel comfortable having conversations with patients about their opioid use disorder. 0.299 3.63 3.53
Background
Purpose
• Provide education to emergency department staff
• Start an ED and Urgent Care bridging program
• Provide additional education based on survey feedback
• Assess prescribing rates in one year 
Department Pre-Education Post-Education
All participants 59 19
Pharmacists 6 4
Nurses 37 5
Case managers & social 
workers
10 10
Hospitalists 6 0
Results Table 2: Prescribing Data
Results
# of patients newly 
initiated on MAT
# of patients 
continued on MAT
3 months pre-education 2 2
3 months post-education 4 9
Nursing
• Increased confidence in recognizing symptoms of withdrawal (p=0.0178)
• Increased comfort in asking patients about their withdrawal (p=0.0392)
• Increased comfort in administering the COWS assessment (p=0.0108)
Pharmacy
• Increased confidence in speaking to the advantages and disadvantages of 
buprenorphine versus methadone (p=0.0129)
• Increased comfort in providing dosing recommendations (p=0.0402)
Case Management
• No change in feelings that there is an adequate pathway to place these 
patients upon discharge
Hospitalists
• No hospitalists responded to the post-education survey assessing their 
knowledge surrounding MAT laws in the hospital, comfort level with these 
medications, and the likelihood of initiation 
Results Table 3: Number of Survey Participants
Conclusions
Overall, there was an increase knowledge base in most areas post-
education, however, change in comfort level was not unanimous within the 
interdisciplinary team. There were more patients prescribed MAT for OUD 
post-education. During the timeframe that there were buprenorphine and 
methadone induction order sets, MAT initiation rate tripled. Continued 
education and experience for caregivers is still recommended to further 
increase knowledge and comfort level.
